LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

Neogen Corp

Slēgts

SektorsVeselības aprūpe

4.71 -1.67

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.59

Max

4.81

Galvenie mērījumi

By Trading Economics

Ienākumi

445M

-11M

Pārdošana

-10M

221M

P/E

Sektora vidējais

657.5

50.291

EPS

0.1

Peļņas marža

-4.958

Darbinieki

2,917

EBITDA

495M

37M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+84.8% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 29. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-1.1B

1.1B

Iepriekšējā atvēršanas cena

6.38

Iepriekšējā slēgšanas cena

4.71

Ziņu noskaņojums

By Acuity

50%

50%

154 / 380 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Neogen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 26. jūn. 23:49 UTC

Peļņas

Nike Sees Sales Decline Decelerating in 1Q as Turnaround Strategy Plays Out -- 2nd Update

2025. g. 26. jūn. 22:19 UTC

Iegādes, apvienošanās, pārņemšana

FTC Clears Alimentation Couche-Tard's $1.57 Billion GetGo Acquisition

2025. g. 26. jūn. 21:30 UTC

Peļņas

Nike 4Q Profit, Revenue Slides as Turnaround Strategy Plays Out -- Update

2025. g. 26. jūn. 21:07 UTC

Peļņas

Nike 4Q Profit, Revenue Slide as Turnaround Strategy Plays Out

2025. g. 26. jūn. 23:49 UTC

Tirgus saruna

Nikkei May Rise as Fears About Middle East Conflict Ebb -- Market Talk

2025. g. 26. jūn. 23:39 UTC

Tirgus saruna

Gold Edges Lower, Weighed by Stronger-Than-Expected U.S. Data -- Market Talk

2025. g. 26. jūn. 23:34 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: Lease Reset Provides Opportunity for Upgrades, Extensions

2025. g. 26. jūn. 23:33 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: 62 BWP-Owned Bunnings Sites Get Significantly Longer Leases

2025. g. 26. jūn. 23:32 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers Will No Longer Receive Earnings From BWP Management

2025. g. 26. jūn. 23:32 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers to Increase BWP Holding to 23.5% From 22.3%

2025. g. 26. jūn. 23:31 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: New BWP Units Priced at 9.2% Premium to Last Close

2025. g. 26. jūn. 23:31 UTC

Iegādes, apvienošanās, pārņemšana

BWP to Pay A$100 Mln Cash, A$42.6 Mln in New Units

2025. g. 26. jūn. 23:30 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers' Bunnings, BWP Trust to Extend and Vary Leases

2025. g. 26. jūn. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers to Sell BWP Management to BWP Trust for A$142.6M

2025. g. 26. jūn. 23:19 UTC

Iegādes, apvienošanās, pārņemšana

Andlauer Healthcare Group: Ontario Superior Court of Justice Issues Final Order Approving Sale to UPS

2025. g. 26. jūn. 22:06 UTC

Peļņas

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

2025. g. 26. jūn. 21:15 UTC

Peļņas

Nike 4Q Profit, Rev Slides as Turnaround Strategy Plays Out -- Update

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: 35 Stores to Be Divested in Accordance With Regulatory Requirements >ATD.T

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: GetGo Will Operate as Separate, Stand-Alone Business Unit, Maintain myPerks Loyalty Program >ATD.T

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: Buyer Will be Approved by the FTC >ATD.T

2025. g. 26. jūn. 21:07 UTC

Peļņas

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

2025. g. 26. jūn. 21:06 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard Agreed to Sell 35 Sites, Including 34 Circle K Locations and One GetGo Property >ATD.T

2025. g. 26. jūn. 21:06 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: Transaction Is Expected to Close in the Coming Days >ATD.T

2025. g. 26. jūn. 21:06 UTC

Tirgus saruna

Bank of Mexico Seen Likely to Slow Pace of Rate Cuts -- Market Talk

2025. g. 26. jūn. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

2025. g. 26. jūn. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

2025. g. 26. jūn. 20:52 UTC

Peļņas

Nike 4Q Profit, Rev Slide as Turnaround Strategy Plays Out

2025. g. 26. jūn. 20:51 UTC

Peļņas

Correct: Nike 4Q Net $211M, Not $200M >NKE

2025. g. 26. jūn. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 26. jūn. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Neogen Corp Prognoze

Cenas mērķis

By TipRanks

84.8% augšup

Prognoze 12 mēnešiem

Vidējais 9 USD  84.8%

Augstākais 13 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Neogen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

2

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.17 / 5.99Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

154 / 380 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.